3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)-N,N-dimethylbenzamide

ID: ALA2204980

PubChem CID: 56943106

Max Phase: Preclinical

Molecular Formula: C23H26F3N7O2

Molecular Weight: 489.50

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN(C)C(=O)c1ccc(Nc2ncnc(N3CCC(c4nc(C(C)(C)F)no4)CC3)c2F)c(F)c1

Standard InChI:  InChI=1S/C23H26F3N7O2/c1-23(2,26)22-30-20(35-31-22)13-7-9-33(10-8-13)19-17(25)18(27-12-28-19)29-16-6-5-14(11-15(16)24)21(34)32(3)4/h5-6,11-13H,7-10H2,1-4H3,(H,27,28,29)

Standard InChI Key:  XGJZRVVCWLCQCJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
    6.9082   -4.5624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7332   -4.5624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1435   -3.8519    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7332   -3.1369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9082   -3.1369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4935   -3.8519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9640   -3.8520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3749   -4.5687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1991   -4.5702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6134   -3.8558    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1975   -3.1383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3746   -3.1404    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6674   -3.8556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1824   -3.1878    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3972   -3.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3997   -4.2701    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1863   -4.5216    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7288   -2.9604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9000   -2.9541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3083   -3.6708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7208   -2.1333    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.9607   -5.2821    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.6103   -5.2854    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.4353   -5.2869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8409   -6.0023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6651   -6.0043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0799   -5.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6642   -4.5724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8414   -4.5740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4249   -6.7147    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.9049   -5.2904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3177   -4.5762    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.3170   -6.0052    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9041   -6.7193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1420   -6.0056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  3  7  1  0
 14 15  1  0
 13 14  2  0
 15 16  2  0
 16 17  1  0
 17 13  1  0
  6 13  1  0
 15 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
  8 22  1  0
  9 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 25 30  1  0
 27 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 33 35  1  0
M  END

Associated Targets(Human)

GPR119 Tclin Glucose-dependent insulinotropic receptor (4762 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rhesus monkey (3147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 489.50Molecular Weight (Monoisotopic): 489.2100AlogP: 4.17#Rotatable Bonds: 6
Polar Surface Area: 100.28Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.73CX Basic pKa: 3.59CX LogP: 3.88CX LogD: 3.88
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.55Np Likeness Score: -2.02

References

1. Abdel-Magid AF..  (2012)  GPR119 Modulators for the Treatment of Diabetes, Obesity, and Related Diseases: Patent Highlight.,  (12): [PMID:24900416] [10.1021/ml300296q]

Source